StockPriceToday
Intuitive Surgical Inc (ISRG)
About Intuitive Surgical Inc
Intuitive Surgical Inc. develops, manufactures, and markets robotic surgical systems designed to enable minimally invasive surgery worldwide. The company's pioneering role in robotic surgery has made ISRG stock price sensitive to surgical procedure volumes and adoption rates of robotic surgical technology.
Intuitive Surgical's da Vinci surgical system allows surgeons to perform complex procedures through small incisions using robotic technology, resulting in potentially faster patient recovery times and improved surgical outcomes. The company's systems are used across various surgical specialties including urology, gynecology, and general surgery.
The company generates revenue through system sales, instrument and accessory sales, and service contracts, creating multiple revenue streams from its installed base. Intuitive Surgical's recurring revenue from instruments and services provides stability while new system placements drive growth, positively affecting ISRG stock price trends.
Intuitive Surgical's continued innovation in robotic surgical technology and expansion into new surgical applications position it well for long-term growth in the medical device market. The company's strong market position and the increasing adoption of minimally invasive surgical techniques remain important factors in its market valuation and future success.
ISRG Stock 12 Month Chart
Latest News for ISRG
Intuitive Surgical, Inc. (ISRG) ended the recent trading session at $423.96, demonstrating a +2.06% change from the preceding day's closing price. The stock outpaced the S&P 500's daily gain of 0.6%.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) ...
During the October 5 episode of Mad Money, a caller asked whether Intuitive Surgical, Inc. (NASDAQ:ISRG) was a broken stock and whether they should consider buying it. Jim Cramer replied: I don’t like ...
Other Popular Stocks
Prelude Therapeutics Incorporated (PRLD) is a clinical-stage precision oncology company developing targeted therapies for patients with cancer by focusing on key drivers of cancer...
Keurig Dr Pepper Inc. operates as a beverage company that manufactures and distributes hot and cold beverages including coffee, tea, juices, and soft drinks...
Contineum Therapeutics Inc. (CTNM) is a clinical-stage biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases and related disorders.